OrbiMed’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Sell |
|
|||||
|
2025
Q1 | $93.5M | Sell |
|
|||||
|
2024
Q4 | $97.8M | Buy |
|
|||||
|
2024
Q3 | $68.8M | Hold |
|
|||||
|
2024
Q2 | $60.8M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $15.2M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $50.1K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $125M | Hold |
|
|||||
|
2018
Q1 | $151M | Buy |
|
|||||
|
2017
Q4 | $120M | Sell |
|
|||||
|
2017
Q3 | $127M | Buy |
|
|||||
|
2017
Q2 | $51M | Buy |
|
|||||
|
2017
Q1 | $4.21M | Buy |
|